Thrivent Financial for Lutherans
SRDX

Thrivent Financial for Lutherans’s Surmodics SRDX Stock Holding History

Thrivent Financial for Lutherans’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,366
Closed -$490K – 2503
2022
Q4 		$490K Sell
14,366
-111
-0.8% -$3.72K ﹤0.01% 2127
2022
Q3 		$440K Buy
14,477
+733
+5% +$25.1K ﹤0.01% 2117
2022
Q2 		$512K Buy
13,744
+2,367
+21% +$91.8K ﹤0.01% 2085
2022
Q1 		$516K Buy
11,377
+88
+0.8% +$3.85K ﹤0.01% 2180
2021
Q4 		$544K Buy
11,289
+76
+0.7% +$3.83K ﹤0.01% 2162
2021
Q3 		$623K Sell
11,213
-2,550
-19% -$142K ﹤0.01% 2079
2021
Q2 		$747K Buy
13,763
+37
+0.3% +$2.03K ﹤0.01% 2008
2021
Q1 		$770K Sell
13,726
-3,231
-19% -$161K ﹤0.01% 2022
2020
Q4 		$738K Hold
16,957
– – ﹤0.01% 1952
2020
Q3 		$660K Sell
16,957
-76
-0.4% -$3.34K ﹤0.01% 1829
2020
Q2 		$737K Buy
17,033
+35
+0.2% +$1.32K ﹤0.01% 1704
2020
Q1 		$566K Buy
16,998
+567
+3% +$20.5K ﹤0.01% 1649
2019
Q4 		$681K Buy
16,431
+5,603
+52% +$236K ﹤0.01% 1723
2019
Q3 		$495K Buy
10,828
+251
+2% +$10.9K ﹤0.01% 1839
2019
Q2 		$457K Buy
10,577
+351
+3% +$14.8K ﹤0.01% 1873
2019
Q1 		$445K Buy
10,226
+811
+9% +$41.3K ﹤0.01% 1854
2018
Q4 		$445K Buy
9,415
+207
+2% +$12.4K ﹤0.01% 1637
2018
Q3 		$687K Buy
9,208
+113
+1% +$7.78K ﹤0.01% 1506
2018
Q2 		$502K Buy
9,095
+605
+7% +$27.9K ﹤0.01% 1684
2018
Q1 		$323K Buy
8,490
+298
+4% +$9.23K ﹤0.01% 1835
2017
Q4 		$229K Buy
8,192
+162
+2% +$4.95K ﹤0.01% 1955
2017
Q3 		$249K Buy
8,030
+10
+0.1% +$272 ﹤0.01% 1835
2017
Q2 		$226K Buy
+8,020
New +$194K ﹤0.01% 1833
2016
Q4 		– Sell
-6,690
Closed -$201K – 2025
2016
Q3 		$201K Buy
+6,690
New +$184K ﹤0.01% 1826

Other funds holding SRDX

TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Thrivent Financial for Lutherans's SRDX Position: Q1 2023 in Review

Thrivent Financial for Lutherans sold out of Surmodics (SRDX) in Q1 2023, closing a stake of 14,366 shares — an estimated $490K sold.

Thrivent Financial for Lutherans first reported a position in SRDX in Q3 2016 and held it in 24 quarters. The position peaked at $770K in Q1 2021. 119 funds tracked by Wall St. Rank hold SRDX as of Q1 2023.

  • Thrivent Financial for Lutherans reported no remaining Surmodics position as of Q1 2023 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 14,366 Surmodics shares in Q1 2023, an estimated $490K.
  • Thrivent Financial for Lutherans first reported a position in Surmodics in Q3 2016 and held it in 24 quarters.
  • Thrivent Financial for Lutherans's Surmodics position peaked at $770K in Q1 2021.
  • 119 funds tracked by Wall St. Rank held Surmodics as of Q1 2023.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2023, filed 17 May 2023.